Healthcare - Biotechnology - NASDAQ - US
$ 0.8181
-3.24 %
$ 5.65 M
Market Cap
-0.53
P/E
CASH FLOW STATEMENT
-8.45 M
OPERATING CASH FLOW
0
INVESTING CASH FLOW
11.3 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Hoth Therapeutics, Inc.
| Net Income | -7.85 M |
| Depreciation & Amortization | 7.69 M |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 216 K |
| Change in Working Capital | -748 K |
| Others | -117 K |
| Free Cash Flow | -8.45 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||
| Net Income | (7.8) | (11.4) | (14.3) | (7.2) | (7.7) | (2.5) | (2.0) |
| Depreciation & Amortization | 0 | 0 | 0 | 1.04 K | 1.22 K | 1.22 K | 188 |
| Deferred Income Tax | 0 | 0 | 0 | 49.4 K | 3.66 K | 0 | 0 |
| Stock Based Compensation | 0.2 | 0.6 | 1.3 | 0.7 | 2.5 | 0.1 | 1.5 |
| Other Operating Activities | 70.1 K | 0.9 | 0.4 | 0.5 | 95 K | 0.2 | 1.5 |
| Change in Working Capital | (0.7) | 0.6 | 0.5 | (0.1) | 0.2 | 80.5 K | 49.5 K |
| Cash From Operations | (8.4) | (9.3) | (12.1) | (6.1) | (4.9) | (2.1) | (0.5) |
| INVESTING CASH FLOW | |||||||
| Capital Expenditures | 0 | 74 K | (0.1) | (0.2) | 95 K | 0 | (0.3) |
| Other Items | 0 | 1.2 | 48.4 K | (1.7) | (0.8) | 0 | 0 |
| Cash From Investing Activities | 0 | 1.2 | (0.2) | (1.8) | (0.9) | 0 | (0.3) |
| FINANCING CASH FLOW | |||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.36 K | 51 K | 0.4 | 56.2 K | 163 | 1.2 | 9 K |
| Cash From Financing Activities | 11.3 | 6.0 | 18.2 | 8.7 | 7.5 | 1.2 | 2.0 |
| CHANGE IN CASH | |||||||
| Net Change In Cash | 2.9 | (2.1) | 5.9 | 0.7 | 1.6 | (0.9) | 1.2 |
| FREE CASH FLOW | |||||||
| Free Cash Flow | (8.4) | (9.4) | (12.2) | (6.3) | (5.0) | (2.1) | (0.8) |